| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| July 23, 2026 | ±3.5% | -1.1% | over-priced |
| April 23, 2026 | ±3.5% | -0.7% | over-priced |
| October 23, 2025 | ±7.3% | +2.2% | over-priced |
| July 24, 2025 | ±2.8% | +0.1% | over-priced |
| April 24, 2025 | ±4.3% | +4.8% | under-priced |
| October 24, 2024 | ±2.1% | -14.7% | under-priced |
| July 25, 2024 | ±2.4% | -4.2% | under-priced |
| April 29, 2024 | ±4.9% | -1.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.06 | $6.1B | $2.3B |
| Q1 FY2026 | $3.00 | $7.3B | $3.3B |
| Q4 FY2025 | $1.19 | $6.8B | $1.3B |
| Q3 FY2025 | $1.67 | $5.5B | $1.8B |
Newmont Corporation (NEM) reports in 108 days, with the next report estimated for November 13, 2026. Across the last 8 reports, options priced an average ±3.8% earnings move while the stock actually moved 3.6% on average — the market has been roughly fair on NEM's earnings risk. Fundamentals into the print: EPS up 11.4% year-over-year, revenue up 15.1%. QuantLogix's live 5-factor engine currently reads NEM as a sell at 41/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →